FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097981 [Registered on: 24/11/2025] Trial Registered Prospectively
Last Modified On: 20/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF NARAYANA TAILA MATRA BASTI AND MUSALI-BAKUCI CHURNA ALONG WITH URDHWAJATRUGATA ABHYANGA IN THE MANAGEMENT OF BADHIRYA (SENSORI-NEURAL HEARING LOSS) 
Scientific Title of Study   A Single Arm Clinical Study to evaluate the efficacy of Narayana Taila Matra Basti and Musali-Bakuci Churna along with Urdhwajatrugata Abhyanga in the management of Badhirya (Sensori-Neural Hearing Loss)” 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nitika  
Designation  P.G. Scholar 
Affiliation  INSTITUTE FOR AYURVED STUDIES AND RESEARCH  
Address  Room No 108 PG Department of Shalakya Tantra
Institute For Ayurved Studies And Research, Umri Road, Sector 8, Kurukshetra
Kurukshetra
HARYANA
136118
India 
Phone  8398963449  
Fax    
Email  nitihooda83989@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashu 
Designation  Professor, Department of Shalakya Tantra 
Affiliation  INSTITUTE FOR AYURVED STUDIES AND RESEARCH  
Address  Room No 108 PG Department of Shalakya Tantra
Institute For Ayurved Studies And Research, Umri Road, Sector 8, Kurukshetra
Kurukshetra
HARYANA
136118
India 
Phone  9416553131  
Fax    
Email  drashukataria@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashu 
Designation  Professor, Department of Shalakya Tantra 
Affiliation  INSTITUTE FOR AYURVED STUDIES AND RESEARCH  
Address  Room No 108 PG Department of Shalakya Tantra
Institute For Ayurved Studies And Research, Umri Road, Sector 8, Kurukshetra
Kurukshetra
HARYANA
136118
India 
Phone  9416553131  
Fax    
Email  drashukataria@gmail.com  
 
Source of Monetary or Material Support  
Institute For Ayurved Studies And Research, Umri road, sector 8, Kurukshetra pin 136118, Haryana, India  
 
Primary Sponsor  
Name  Institute For Ayurved Studies And Research, Umri road, sector 8, Kurukshetra  
Address  Umri road, sector 8, Kurukshetra Pin 136118, Haryana, India  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nitika  Institute for Ayurved Studies and Research  Room no 50, PG Department of Shalakya Tantra Institute for Ayurved Studies and Research Umri road sector 8 KURUKSHETRA Kurukshetra HARYANA
Kurukshetra
HARYANA 
8398963449

nitihooda83989@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri Krishna Ayush University   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H905||Unspecified sensorineural hearingloss. Ayurveda Condition: BADHIRYAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Bhaishajya Ratnavali with Vidyotani Hindi commentary. Vatavyadhi Chikitsa, Chapter 26/330–337, Procedure details: y. Study of Matra Basti will be completed in 2 cycles of 14-14 days with a gap period of 14 days in between. In this gap period Urdhwajatrugata Abhyanga with Tila Taila will be done and Musali- Bakuci Churna will be given orally continuously for 56 days of study. )
(1) Medicine Name: musali bakuci churna, Reference: Rasa Ratna Samuchchya. 9th ed. Edited by Shastri A. Shloka 24/12, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Duration: 56 Days
(2) Medicine Name: narayana taila, Reference: Bhaishajya Ratnavali with Vidyotani Hindi commentary. Vatavyadhi Chikitsa, Chapter 26/330–337, Route: Rectal, Dosage Form: Taila, Dose: 72(ml), Frequency: od, Duration: 28 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having signs and symptoms of Badhirya (SNHL) with mild (26-40 dB), moderate (41-55 dB) and moderately severe (56-70dB) hearing loss will be selected.
Patients having sign and symptoms of Badhirya (SNHL) persisting upto less than 1
year.
Patients having associated symptoms of Badhirya i.e. Karnanada.
The patient is willing and able to participate in the study.
 
 
ExclusionCriteria 
Details  Patients with congenital hearing loss and age above 60 years.
2. Patients with a profound degree of hearing impairment (greater than 70 dB).
3. Patients having symptoms of Badhirya (SNHL) persisting for more than 12 months.
4. Patients with Otorrhoea.
5. Conductive & mixed hearing loss.
6. Pregnant women
7. Patients who require otological surgical intervention.
8. Malignancy related to the external, middle, and internal ear.
9. Patients with systemic illnesses like DM, Hypertension, Tuberculosis…etc. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in scoring pattern of sign and symptoms of Badhirya (Sensorineural Hearing Loss)
 
Reduction in scoring pattern of sign and symptoms of Badhirya (Sensorineural Hearing Loss)
 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in associated symptoms of Badhirya i.e karnanada
Improvement in Quality of Life by a validated questionare (QOL) 
Improvement in associated symptoms of Badhirya i.e karnanada
Improvement in Quality of Life by a validated questionare (QOL) 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In Sense organs are essential for human life, allowing us to perceive and interact with our surroundings. Any disruption in their function can lead to significant challenges. Hearing impairment is one of the most common sensory disabilities, affecting millions of people worldwide. It can hinder the ability to perceive speech, leading to communication difficulties, delayed language development, social isolation, stigmatization, and disadvantages in both education and employment. Ayurveda, the term ‘Badha’ means obstruction, and ‘Badhirya’ refers to the condition that obstructs hearing. Acharya Sushruta classified Badhirya as one of the 28 Karnarogas (ear diseases). He explained that when the Vata and Kapha doshas become vitiated and accumulate in the Siras, they affect the Shabdanuvaha Siras (auditory nerve) in the Shrotrendriya (organ of hearing). This leads to Srotorodha (blockage of the auditory channels), and if left untreated, results in Badhirya . Similarly, Acharya Vagbhata described Badhirya as being caused by vitiated Vayu along with Kapha, particularly when early signs like Karnanada (ringing in the ears) are ignored . Hearing impairment is defined as the partial or complete loss of hearing in one or both ears. Its clinical symptoms closely align with the condition known as Badhirya in Ayurveda and may be either present at birth (congenital) or develop later in life (acquired).  In modern medicine, hearing loss is generally classified into three types : 1.Conductive, 2.Sensori-neural,3.Mixed. Conductive hearing loss (CHL) occurs due to an obstruction in the transmission of sound from the external ear to the stapediovestibular joint. Sensori-Neural hearing loss (SNHL) results from damage to the cochlea, the vestibulocochlear nerve, or related central pathways. Mixed hearing loss includes elements of both conductive and Sensori-neural types. Hearing loss affects one’s quality of life depending on the severity of hearing loss. Hearing aids, implants, and assistive devices are most common instrumental devices which are used in rehabilitation of the impaired hearing. Despite their success, hearing aids and cochlear implants are not perfect in all situations.  In more severe cases where conventional hearing aids are inadequate, cochlear implants may be considered. Despite these options, the high cost of modern treatments often makes them inaccessible for the average person in India. Ayurvedic treatment presents a potentially affordable and effective alternative. Therefore, this study seeks to evaluate the use of Ayurvedic therapies as a cost-efficient and safe approach for managing hearing impairment. Being a complete medical science, Ayurveda possesses many wonders, which are still beyond our site & understanding. Hence, to find out such phenomenon of Ayurveda, Badhirya (SNHL) has been selected for the present study. Narayana Taila Basti is described in classical texts for Badhirya and Musali-Bakuci Churna mixed in equal quantity along with Madhu is also described in classical ayurvedic texts for Badhirya. With the administration of Snehana dravyas, the Vayu is eliminated & Mridutva in the body is produced. The vitiated Doshas, which obstructs the srotas, are eliminated with the help of snehana.By employing a randomized open-label clinical trial design, this research aims to generate scientific evidence for the effectiveness of Narayana Taila Matra Basti along with MusaliBakuci Churna orally potentially establishing it as a viable, natural alternative to modern pharmacotherapy.  
Close